LB-2311
N/A
Report date: 2025/11/10 13:24:25
NME
Base Information
Drug NameLB-2311
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhuhai United Laboratories Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesZhuhai United Laboratories Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A